The role for IGF-1-derived small neuropeptides as a therapeutic target for neurological disorders

J Guan, P Harris, M Brimble, Y Lei, J Lu… - Expert opinion on …, 2015 - Taylor & Francis
Introduction: Exogenous IGF-1 protects the brain from ischemic injury and improves function.
However, its clinical application to neurological disorders is limited by its large molecular …

Tripeptide motifs in biology: targets for peptidomimetic design

P Ung, DA Winkler - Journal of medicinal chemistry, 2011 - ACS Publications
The concept that nature tends to reuse motifs and structural components is commonly
understood. In the case of proteins and peptides, common structural motifs such as helices …

Synthesis of the tetracyclic core skeleton of the lundurines by a gold-catalyzed cyclization

C Ferrer, A Escribano-Cuesta, AM Echavarren - Tetrahedron, 2009 - Elsevier
Synthesis of the tetracyclic core skeleton of the lundurines by a gold-catalyzed cyclization -
ScienceDirect Skip to main contentSkip to article Elsevier logo Journals & Books Search …

Concise overview of glypromate neuropeptide research: from chemistry to pharmacological applications in neurosciences

SC Silva-Reis, IE Sampaio-Dias… - ACS Chemical …, 2023 - ACS Publications
Neurodegenerative diseases of the central nervous system (CNS) pose a serious health
concern worldwide, with a particular incidence in developed countries as a result of life …

[HTML][HTML] Development of trofinetide for the treatment of Rett syndrome: from bench to bedside

M Kennedy, L Glass, DG Glaze, S Kaminsky… - Frontiers in …, 2024 - frontiersin.org
Rett syndrome (RTT) is rare neurodevelopmental disorder caused by mutations in the
MECP2 gene that encodes methyl-CpG-binding protein 2 (MeCP2), a DNA-binding protein …

IGF‐1 derived small neuropeptides and analogues: a novel strategy for the development of pharmaceuticals for neurological conditions

J Guan, PD Gluckman - British journal of pharmacology, 2009 - Wiley Online Library
Insulin‐like growth factor‐1 (IGF‐1) is neuroprotective and improves long‐term function after
brain injury. However, its clinical application to neurological disorders is limited by its large …

NNZ-2566: A Gly–Pro–Glu analogue with neuroprotective efficacy in a rat model of acute focal stroke

MJ Bickerdike, GB Thomas, DC Batchelor… - Journal of the …, 2009 - Elsevier
The N-terminal cleavage product of human insulin-like growth factor-1 (IGF-1) in the brain is
the tripeptide molecule Glypromate®(Gly–Pro–Glu). Glypromate® has demonstrated …

New method of preparation of C2F5Li and its reactions with cyclic imines and lactims: Synthesis of α-pentafluoroethyl proline

NE Shevchenko, VG Nenajdenko… - Journal of Fluorine …, 2008 - Elsevier
Addition of pentafluoroethyllithium to cyclic imines leads to pentafluoroethyl substituted
pyrrolidines, piperidines and azepanes while reaction of cyclic lactims gives rise to 2 …

GPE and GPE analogues as promising neuroprotective agents

I Cacciatore, C Cornacchia… - Mini reviews in …, 2012 - ingentaconnect.com
The tripeptide glycine-proline-glutamate (GPE) is the naturally cleaved N-terminal tripeptide
of insulin-like growth factor-1 (IGF-1) in brain tissues by an acid protease. Although GPE …

Stereoselective synthesis of quaternary proline analogues

MI Calaza, C Cativiela - European journal of organic chemistry, 2008 - Wiley Online Library
This review describes available methods for the diastereoselective and asymmetric
synthesis of quaternary prolines. The focus is on the preparation of α‐functionalized prolines …